ClinicalTrials.gov
ClinicalTrials.gov Menu

XELOX+Bevacizumab Followed by Capecitabine+Bevacizumab+Radiotherapy as Neoadjuvant Treatment of Locally Advanced Rectal Adenocarcinoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00557713
Recruitment Status : Unknown
Verified November 2007 by Associacio catalana per a la recerca oncologica i les seves implicacions sanitaries i socials.
Recruitment status was:  Recruiting
First Posted : November 14, 2007
Last Update Posted : November 14, 2007
Sponsor:
Collaborator:
Hoffmann-La Roche
Information provided by:
Associacio catalana per a la recerca oncologica i les seves implicacions sanitaries i socials

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Unknown
  Primary Completion Date : No date given
  Estimated Study Completion Date : October 2013